Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adolor Corporation
Adolor Corporation Reports First Quarter 2009 Financial Results
May 15th, 2009
Adolor Corporation (Nasdaq:ADLR) reported financial results for the three months ended March 31, 2009. Net product sales of ENTEREG® (alvimopan) recognized for the three months ended March 31, 2009 were approximately $1.4 million on total net shipments of approximately $2.0 million. Under Adolor's current revenue recognition policy, revenue related to a customer shipment is deferred until subsequent re-orders by that customer. Since the Company's launch of ENTEREG in June 2008, approximately 300 hospitals have re-ordered the product. Hospitals registered under the ENTEREG Access Support and Education (E.A.S.E.™) Program increased by 175 to...
Source: Health Business Week (2009-05-15)
|
